nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalidixic Acid—Cranial nerve paralysis—Methotrexate—urinary bladder cancer	0.0495	0.0495	CcSEcCtD
Nalidixic Acid—Papilloedema—Cisplatin—urinary bladder cancer	0.0327	0.0327	CcSEcCtD
Nalidixic Acid—Metabolic acidosis—Etoposide—urinary bladder cancer	0.0241	0.0241	CcSEcCtD
Nalidixic Acid—Optic neuritis—Cisplatin—urinary bladder cancer	0.0169	0.0169	CcSEcCtD
Nalidixic Acid—Optic neuritis—Etoposide—urinary bladder cancer	0.0155	0.0155	CcSEcCtD
Nalidixic Acid—Blister—Fluorouracil—urinary bladder cancer	0.0152	0.0152	CcSEcCtD
Nalidixic Acid—Drowsiness—Mitomycin—urinary bladder cancer	0.0148	0.0148	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Valrubicin—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Nalidixic Acid—Erythema—Mitomycin—urinary bladder cancer	0.0115	0.0115	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Valrubicin—urinary bladder cancer	0.0112	0.0112	CcSEcCtD
Nalidixic Acid—Abdominal pain—Valrubicin—urinary bladder cancer	0.0108	0.0108	CcSEcCtD
Nalidixic Acid—Leukopenia—Mitomycin—urinary bladder cancer	0.0103	0.0103	CcSEcCtD
Nalidixic Acid—Asthenia—Valrubicin—urinary bladder cancer	0.0098	0.0098	CcSEcCtD
Nalidixic Acid—Pruritus—Valrubicin—urinary bladder cancer	0.00967	0.00967	CcSEcCtD
Nalidixic Acid—Diarrhoea—Valrubicin—urinary bladder cancer	0.00935	0.00935	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00922	0.00922	CcSEcCtD
Nalidixic Acid—Dizziness—Valrubicin—urinary bladder cancer	0.00904	0.00904	CcSEcCtD
Nalidixic Acid—Swelling—Fluorouracil—urinary bladder cancer	0.00903	0.00903	CcSEcCtD
Nalidixic Acid—Vomiting—Valrubicin—urinary bladder cancer	0.00869	0.00869	CcSEcCtD
Nalidixic Acid—Optic neuritis—Epirubicin—urinary bladder cancer	0.00869	0.00869	CcSEcCtD
Nalidixic Acid—Rash—Valrubicin—urinary bladder cancer	0.00862	0.00862	CcSEcCtD
Nalidixic Acid—Dermatitis—Valrubicin—urinary bladder cancer	0.00861	0.00861	CcSEcCtD
Nalidixic Acid—Headache—Valrubicin—urinary bladder cancer	0.00856	0.00856	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Gemcitabine—urinary bladder cancer	0.00848	0.00848	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Gemcitabine—urinary bladder cancer	0.00837	0.00837	CcSEcCtD
Nalidixic Acid—Somnolence—Mitomycin—urinary bladder cancer	0.00837	0.00837	CcSEcCtD
Nalidixic Acid—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.00837	0.00837	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Fluorouracil—urinary bladder cancer	0.00834	0.00834	CcSEcCtD
Nalidixic Acid—Nausea—Valrubicin—urinary bladder cancer	0.00812	0.00812	CcSEcCtD
Nalidixic Acid—Optic neuritis—Doxorubicin—urinary bladder cancer	0.00804	0.00804	CcSEcCtD
Nalidixic Acid—Swelling—Etoposide—urinary bladder cancer	0.00784	0.00784	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Cisplatin—urinary bladder cancer	0.0078	0.0078	CcSEcCtD
Nalidixic Acid—Blister—Epirubicin—urinary bladder cancer	0.00741	0.00741	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Etoposide—urinary bladder cancer	0.00715	0.00715	CcSEcCtD
Nalidixic Acid—Blister—Doxorubicin—urinary bladder cancer	0.00686	0.00686	CcSEcCtD
Nalidixic Acid—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00682	0.00682	CcSEcCtD
Nalidixic Acid—Asthenia—Mitomycin—urinary bladder cancer	0.00675	0.00675	CcSEcCtD
Nalidixic Acid—Diarrhoea—Mitomycin—urinary bladder cancer	0.00644	0.00644	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00629	0.00629	CcSEcCtD
Nalidixic Acid—Dizziness—Mitomycin—urinary bladder cancer	0.00623	0.00623	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.00619	0.00619	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Gemcitabine—urinary bladder cancer	0.00612	0.00612	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Fluorouracil—urinary bladder cancer	0.00602	0.00602	CcSEcCtD
Nalidixic Acid—Vomiting—Mitomycin—urinary bladder cancer	0.00599	0.00599	CcSEcCtD
Nalidixic Acid—Rash—Mitomycin—urinary bladder cancer	0.00594	0.00594	CcSEcCtD
Nalidixic Acid—Dermatitis—Mitomycin—urinary bladder cancer	0.00593	0.00593	CcSEcCtD
Nalidixic Acid—Headache—Mitomycin—urinary bladder cancer	0.0059	0.0059	CcSEcCtD
Nalidixic Acid—Erythema—Thiotepa—urinary bladder cancer	0.0058	0.0058	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Cisplatin—urinary bladder cancer	0.00571	0.00571	CcSEcCtD
Nalidixic Acid—Nausea—Mitomycin—urinary bladder cancer	0.00559	0.00559	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.0053	0.0053	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00529	0.00529	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Etoposide—urinary bladder cancer	0.00523	0.00523	CcSEcCtD
Nalidixic Acid—Leukopenia—Thiotepa—urinary bladder cancer	0.00519	0.00519	CcSEcCtD
Nalidixic Acid—Visual impairment—Cisplatin—urinary bladder cancer	0.00504	0.00504	CcSEcCtD
Nalidixic Acid—Convulsion—Thiotepa—urinary bladder cancer	0.00503	0.00503	CcSEcCtD
Nalidixic Acid—Arthralgia—Thiotepa—urinary bladder cancer	0.00494	0.00494	CcSEcCtD
Nalidixic Acid—Erythema—Gemcitabine—urinary bladder cancer	0.00488	0.00488	CcSEcCtD
Nalidixic Acid—Erythema—Fluorouracil—urinary bladder cancer	0.0048	0.0048	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00464	0.00464	CcSEcCtD
Nalidixic Acid—Erythema—Cisplatin—urinary bladder cancer	0.00455	0.00455	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Etoposide—urinary bladder cancer	0.00453	0.00453	CcSEcCtD
Nalidixic Acid—Leukopenia—Gemcitabine—urinary bladder cancer	0.00437	0.00437	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00431	0.00431	CcSEcCtD
Nalidixic Acid—Leukopenia—Fluorouracil—urinary bladder cancer	0.00429	0.00429	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Methotrexate—urinary bladder cancer	0.00428	0.00428	CcSEcCtD
Nalidixic Acid—Paraesthesia—Thiotepa—urinary bladder cancer	0.00425	0.00425	CcSEcCtD
Nalidixic Acid—Somnolence—Thiotepa—urinary bladder cancer	0.00421	0.00421	CcSEcCtD
Nalidixic Acid—Convulsion—Fluorouracil—urinary bladder cancer	0.00416	0.00416	CcSEcCtD
Nalidixic Acid—Arthralgia—Gemcitabine—urinary bladder cancer	0.00415	0.00415	CcSEcCtD
Nalidixic Acid—Leukopenia—Cisplatin—urinary bladder cancer	0.00407	0.00407	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Epirubicin—urinary bladder cancer	0.00406	0.00406	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Epirubicin—urinary bladder cancer	0.00401	0.00401	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00398	0.00398	CcSEcCtD
Nalidixic Acid—Convulsion—Cisplatin—urinary bladder cancer	0.00394	0.00394	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Nalidixic Acid—Diplopia—Epirubicin—urinary bladder cancer	0.00388	0.00388	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00387	0.00387	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00383	0.00383	CcSEcCtD
Nalidixic Acid—Urticaria—Thiotepa—urinary bladder cancer	0.00376	0.00376	CcSEcCtD
Nalidixic Acid—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00376	0.00376	CcSEcCtD
Nalidixic Acid—Vertigo—Etoposide—urinary bladder cancer	0.00374	0.00374	CcSEcCtD
Nalidixic Acid—Abdominal pain—Thiotepa—urinary bladder cancer	0.00374	0.00374	CcSEcCtD
Nalidixic Acid—Leukopenia—Etoposide—urinary bladder cancer	0.00373	0.00373	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Nalidixic Acid—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00363	0.00363	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00363	0.00363	CcSEcCtD
Nalidixic Acid—Convulsion—Etoposide—urinary bladder cancer	0.00361	0.00361	CcSEcCtD
Nalidixic Acid—Diplopia—Doxorubicin—urinary bladder cancer	0.00359	0.00359	CcSEcCtD
Nalidixic Acid—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00358	0.00358	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00357	0.00357	CcSEcCtD
Nalidixic Acid—Eosinophilia—Methotrexate—urinary bladder cancer	0.00355	0.00355	CcSEcCtD
Nalidixic Acid—Somnolence—Gemcitabine—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Nalidixic Acid—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00352	0.00352	CcSEcCtD
Nalidixic Acid—Somnolence—Fluorouracil—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Etoposide—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Nalidixic Acid—Asthenia—Thiotepa—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Nalidixic Acid—Pruritus—Thiotepa—urinary bladder cancer	0.00335	0.00335	CcSEcCtD
Nalidixic Acid—Paraesthesia—Cisplatin—urinary bladder cancer	0.00333	0.00333	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00333	0.00333	CcSEcCtD
Nalidixic Acid—Eosinophilia—Epirubicin—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Nalidixic Acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Nalidixic Acid—Drowsiness—Methotrexate—urinary bladder cancer	0.00319	0.00319	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Nalidixic Acid—Dizziness—Thiotepa—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Nalidixic Acid—Urticaria—Fluorouracil—urinary bladder cancer	0.00311	0.00311	CcSEcCtD
Nalidixic Acid—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00307	0.00307	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00306	0.00306	CcSEcCtD
Nalidixic Acid—Paraesthesia—Etoposide—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Nalidixic Acid—Somnolence—Etoposide—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Nalidixic Acid—Vomiting—Thiotepa—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Nalidixic Acid—Drowsiness—Epirubicin—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Nalidixic Acid—Rash—Thiotepa—urinary bladder cancer	0.00299	0.00299	CcSEcCtD
Nalidixic Acid—Dermatitis—Thiotepa—urinary bladder cancer	0.00298	0.00298	CcSEcCtD
Nalidixic Acid—Headache—Thiotepa—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00296	0.00296	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00293	0.00293	CcSEcCtD
Nalidixic Acid—Asthenia—Gemcitabine—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Nalidixic Acid—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Nalidixic Acid—Pruritus—Gemcitabine—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Nalidixic Acid—Nausea—Thiotepa—urinary bladder cancer	0.00281	0.00281	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00278	0.00278	CcSEcCtD
Nalidixic Acid—Pruritus—Fluorouracil—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Nalidixic Acid—Drowsiness—Doxorubicin—urinary bladder cancer	0.00277	0.00277	CcSEcCtD
Nalidixic Acid—Visual impairment—Methotrexate—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Nalidixic Acid—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Nalidixic Acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Nalidixic Acid—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Nalidixic Acid—Urticaria—Etoposide—urinary bladder cancer	0.0027	0.0027	CcSEcCtD
Nalidixic Acid—Abdominal pain—Etoposide—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Nalidixic Acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Nalidixic Acid—Asthenia—Cisplatin—urinary bladder cancer	0.00266	0.00266	CcSEcCtD
Nalidixic Acid—Dizziness—Fluorouracil—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Visual impairment—Epirubicin—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Nalidixic Acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Nalidixic Acid—Vomiting—Gemcitabine—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Nalidixic Acid—Rash—Gemcitabine—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Nalidixic Acid—Dermatitis—Gemcitabine—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Nalidixic Acid—Erythema—Methotrexate—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Nalidixic Acid—Headache—Gemcitabine—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Nalidixic Acid—Vomiting—Fluorouracil—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Nalidixic Acid—Rash—Fluorouracil—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Nalidixic Acid—Dermatitis—Fluorouracil—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Nalidixic Acid—Headache—Fluorouracil—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Nalidixic Acid—Asthenia—Etoposide—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Nalidixic Acid—Pruritus—Etoposide—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Nalidixic Acid—Visual impairment—Doxorubicin—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Nalidixic Acid—Nausea—Gemcitabine—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Nalidixic Acid—Vomiting—Cisplatin—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Nalidixic Acid—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Nalidixic Acid—Rash—Cisplatin—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Nalidixic Acid—Dermatitis—Cisplatin—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Nalidixic Acid—Erythema—Epirubicin—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Nalidixic Acid—Diarrhoea—Etoposide—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Nalidixic Acid—Nausea—Fluorouracil—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Nalidixic Acid—Dizziness—Etoposide—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Nalidixic Acid—Vertigo—Methotrexate—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Nalidixic Acid—Leukopenia—Methotrexate—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Nalidixic Acid—Nausea—Cisplatin—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Nalidixic Acid—Convulsion—Methotrexate—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Nalidixic Acid—Vomiting—Etoposide—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Nalidixic Acid—Erythema—Doxorubicin—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Nalidixic Acid—Rash—Etoposide—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Nalidixic Acid—Dermatitis—Etoposide—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Nalidixic Acid—Headache—Etoposide—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Nalidixic Acid—Arthralgia—Methotrexate—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Nalidixic Acid—Vertigo—Epirubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Nalidixic Acid—Leukopenia—Epirubicin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Nalidixic Acid—Convulsion—Epirubicin—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Nalidixic Acid—Nausea—Etoposide—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Arthralgia—Epirubicin—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Nalidixic Acid—Vertigo—Doxorubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Nalidixic Acid—Leukopenia—Doxorubicin—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Nalidixic Acid—Convulsion—Doxorubicin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Nalidixic Acid—Arthralgia—Doxorubicin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Nalidixic Acid—Paraesthesia—Methotrexate—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Nalidixic Acid—Somnolence—Methotrexate—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Nalidixic Acid—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Nalidixic Acid—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Nalidixic Acid—Paraesthesia—Epirubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Nalidixic Acid—Somnolence—Epirubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Nalidixic Acid—Urticaria—Methotrexate—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Nalidixic Acid—Abdominal pain—Methotrexate—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Nalidixic Acid—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Nalidixic Acid—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Nalidixic Acid—Somnolence—Doxorubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Nalidixic Acid—Urticaria—Epirubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Nalidixic Acid—Abdominal pain—Epirubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Nalidixic Acid—Asthenia—Methotrexate—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Nalidixic Acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Nalidixic Acid—Pruritus—Methotrexate—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Nalidixic Acid—Urticaria—Doxorubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Nalidixic Acid—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Nalidixic Acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Nalidixic Acid—Asthenia—Epirubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Nalidixic Acid—Pruritus—Epirubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Nalidixic Acid—Dizziness—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Nalidixic Acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nalidixic Acid—Vomiting—Methotrexate—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Nalidixic Acid—Rash—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Nalidixic Acid—Dermatitis—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Nalidixic Acid—Headache—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Nalidixic Acid—Asthenia—Doxorubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Nalidixic Acid—Dizziness—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Nalidixic Acid—Pruritus—Doxorubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Nalidixic Acid—Vomiting—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Nalidixic Acid—Nausea—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Nalidixic Acid—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Nalidixic Acid—Rash—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Nalidixic Acid—Dermatitis—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Nalidixic Acid—Headache—Epirubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Nalidixic Acid—Dizziness—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Nalidixic Acid—Nausea—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Nalidixic Acid—Vomiting—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Nalidixic Acid—Rash—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Dermatitis—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Headache—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Nalidixic Acid—Nausea—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
